The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Flecainide 100mg Tablets

Teva B.V.PA1986/050/002

Main Information

Trade NameFlecainide 100mg Tablets
Active SubstancesFlecainide acetate
Dosage FormTablet
Licence HolderTeva B.V.
Licence NumberPA1986/050/002

Group Information

ATC CodeC01BC Antiarrhythmics, class Ic
C01BC04 flecainide


License statusAuthorised
Licence Issued13/06/2006
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back